Selected article for: "disease outbreak and global spread"
Author: El Bairi, Khalid; Trapani, Dario; Petrillo, Angelica; Le Page, Cécile; Zbakh, Hanaa; Daniele, Bruno; Belbaraka, Rhizlane; Curigliano, Giuseppe; Afqir, Said
Title: Repurposing Anticancer Drugs for the Management of COVID-19
  • Cord-id: zzovjqtv
  • Document date: 2020_9_22
    • ID: zzovjqtv
    Snippet: Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion, thus regarded as a global public health emergency. The existing therapeutic options for COVID-19 beyond the intensive supportive care are limited, with an undefined or modest efficacy reported so far. Drug repurposing represents an enthusiastic mechanism to use approved drugs outside the scope of their original indication and accelerate the disc
    Document: Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion, thus regarded as a global public health emergency. The existing therapeutic options for COVID-19 beyond the intensive supportive care are limited, with an undefined or modest efficacy reported so far. Drug repurposing represents an enthusiastic mechanism to use approved drugs outside the scope of their original indication and accelerate the discovery of new therapeutic options. With the emergence of COVID-19, drug repurposing has been largely applied for early clinical testing. In this Review, we discuss some repurposed anticancer drugs for the treatment of COVID-19 and under investigation in clinical trials or proposed for the clinical testing. .

    Search related documents:
    Co phrase search for related documents
    • aberrant activation and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • accessory structural and acute infectious disease: 1, 2
    • accessory structural and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • accessory structural protein and acute sars cov respiratory syndrome coronavirus: 1, 2
    • action mechanism and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • action mechanism and acute infectious disease: 1, 2
    • action mechanism and acute myeloid leukemia: 1, 2, 3, 4, 5
    • action mechanism and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25